myMPNteam

For patients who undergo allogeneic stem cell transplants (bone marrow transplants) for MPNs, the five-year survival rates vary considerably, ranging from 30% to 70%. The outcome tends to be more favorable when the procedure is performed during earlier disease stages.

While these statistics show variability in outcomes Show Full Answer

For patients who undergo allogeneic stem cell transplants (bone marrow transplants) for MPNs, the five-year survival rates vary considerably, ranging from 30% to 70%. The outcome tends to be more favorable when the procedure is performed during earlier disease stages.

While these statistics show variability in outcomes, it's important to note that stem cell transplants remain the only potential cure for MPNs. The success of the transplant can be influenced by several factors, including:
- The genetic match between donor and recipient
- Whether the donor is a sibling or close blood relative
- The risk of complications like graft-versus-host disease (GVHD)

Some patients may need to take anti-rejection medications long-term to prevent GVHD, even with a close genetic match.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Stem Cell Transplants for MPNs: How To Prepare

7 Treatment Options for Myeloproliferative Neoplasms